Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marine Valery"'
Autor:
Anthony Tarabay, Alice Boileve, Cristina Smolenschi, Leony Antoun, Marine Valery, Alina Fuerea, Audrey Perret, Pascal Burtin, Simona Cosconea, Hichem Belkhodja, David Malka, Valérie Boige, Antoine Hollebecque, Michel Ducreux
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2569 (2023)
Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack treatment options. Gene alterations (GAs) are frequently observed
Externí odkaz:
https://doaj.org/article/26a3fb018c8542f2bb1c09dce554c516
Autor:
Marine Valery, Baptiste Cervantes, Ramy Samaha, Maximiliano Gelli, Cristina Smolenschi, Alina Fuerea, Lambros Tselikas, Caroline Klotz-Prieux, Antoine Hollebecque, Valérie Boige, Michel Ducreux
Publikováno v:
Cancers. 14(18)
Immunotherapy has demonstrated its effectiveness in many cancers. In hepatocellular carcinoma (HCC), promising results shown in the first phase II studies evaluating anti-PD-1 or anti-PD-L1 monotherapies resulted in their approval in the United State
Autor:
Imen Ben-Ammar, Michel Ducreux, Valérie Boige, Antoine Hollebecque, Anthony Tarabay, Cristina Smolenschi, Maximiliano Gelli, Marie Laure Tanguy, Marine Valery, Etienne Rouleau, Rémy Barbe, Alice Boileve, Alina Cristina Fuerea
Publikováno v:
Journal of Clinical Oncology. 41:750-750
750 Background: KRAS mutation is the most common molecular alteration (MA) in pancreatic adenocarcinoma (PDAC), and only 8-10% of patients (pts) harbor KRAS wild-type tumors (WT). This study describes clinical and molecular features of KRAS WT PDAC a
Autor:
Cristina Smolenschi, Marine Valery, Alice Boileve, Baptiste Cervantes, Anthony Tarabay, Valerie Boige, Imen Ben-Ammar, Bianca Cheaib, Maximiliano Gelli, Isabelle Sourouille, Leonor Benhaim, Alina Fuerea, Audrey Perret, Michel Ducreux, Antoine Hollebecque
Publikováno v:
Journal of Clinical Oncology. 41:809-809
809 Background: Peritoneal carcinomatosis (PC) is a common manifestation in gastro-intestinal (GI) cancers.10-20 % of patients (pts) will present isolated, unresectable peritoneal disease with poor prognosis. In the past years, circulating tumor DNA
Autor:
Marine Valery, Marie Laure Tanguy, Valérie Boige, Cristina Smolenschi, Antoine Hollebecque, Alina Fuerea, Caroline Klotz-Prieux, Leonor Benhaim, Thierry Debaere, Maximiliano Gelli, Lambros Tselikas, Michel Ducreux, David Malka
Publikováno v:
Journal of Clinical Oncology. 40:95-95
95 Background: Oxaliplatin, a major drug in metastatic colorectal cancer (MCRC), is responsible for a cumulative and limiting peripheral neuropathy (PN). Hepatic arterial infusion (HAI) chemotherapy, which makes sense in cases of exclusive or predomi
Autor:
Emilie Vallet, Aurélien Gobert, P. Tilleul, Jean-Philippe Spano, Philippe Maingon, Donia Lassoued, Marine Valery, A. Bellanger
Publikováno v:
Journal of Clinical Oncology. 37:e14086-e14086
e14086 Background: PD-1 and PD-L1 inhibitors have now demonstrated their efficacy. Finding predictive or pre-emptive response factors is crucial and the role of immune-related adverse events (irAEs) is widely debated. The aim of our study was to eval